You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).
This page has been updated recently.
FDA study reinforces no safety concerns from residual formaldehyde in some infant vaccines
Posted: 4/25/2013
HEMACORD (HPC, cord blood)
Approval Letter and Package Insert, Posted: 4/25/2013
Biologic Product Shortages
Updated: 4/25/2013
Urgent Biological Product Notification Seraclone Anti-S
Posted: 4/25/2013
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
